أعرض في EDS

Supplementary Figure 3 from Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of SAR245408 (XL147), an Oral Pan-Class I PI3K Inhibitor, in Patients with Advanced Solid Tumors

التفاصيل البيبلوغرافية
العنوان: Supplementary Figure 3 from Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of SAR245408 (XL147), an Oral Pan-Class I PI3K Inhibitor, in Patients with Advanced Solid Tumors
المؤلفون: Gerald Edelman, Coumaran Egile, Yi Xu, Linh T. Nguyen, A. Douglas Laird, Christian Scheffold, Shuchi S. Pandya, Irene Braña, Jose Baselga, Eunice L. Kwak, Cynthia Bedell, Jordi Rodon, Geoffrey I. Shapiro
بيانات النشر: American Association for Cancer Research (AACR), 2023.
سنة النشر: 2023
الوصف: PDF file - 6224K, Inhibition of MEK-ERK pathway signaling in tumor biopsies.
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79aa092fb8f6804b8fc0efc97b0f84e7
https://doi.org/10.1158/1078-0432.22448135
حقوق: OPEN
رقم الأكسشن: edsair.doi.dedup.....79aa092fb8f6804b8fc0efc97b0f84e7
قاعدة البيانات: OpenAIRE
الوصف
الوصف غير متاح.